HIV integrase drugs for HIV
9 tracked HIV integrase drugs in the HIV race. The class explanation lives on the HIV integrase page; the full indication pipeline across every mechanism is on the HIV page.
7 approved / phase 41 Phase 31 Phase 2
Head-to-head evidence: ACC017 vs Bictegravir · ACC017 vs Bictegravir/lenacapavir (Bixlenvo) · ACC017 vs Cabotegravir (Apretude) · ACC017 vs Cabotegravir/rilpivirine (Cabenuva) · ACC017 vs Dolutegravir · ACC017 vs Elvitegravir